Fax: (770) 488-4639
National Health Interview Survey, 2008
Article first published online: 20 JUN 2011
Copyright © 2011 American Cancer Society
Volume 117, Issue 24, pages 5612–5620, 15 December 2011
How to Cite
Wong, C. A., Berkowitz, Z., Dorell, C. G., Anhang Price, R., Lee, J. and Saraiya, M. (2011), Human papillomavirus vaccine uptake among 9- to 17-year-old girls. Cancer, 117: 5612–5620. doi: 10.1002/cncr.26246
We thank Shannon Stokely and Robin Curtis for their contributions.
Charlene Wong and Jennifer Lee completed this project during a 1-year fellowship with The CDC Experience, a public/private partnership supported by a grant to the CDC Foundation from External Medical Affairs, Pfizer Inc.
The findings and conclusions in this study are those of the authors and do not necessarily reflect the official position of the Department of Health and Human Services or the Centers for Disease Control and Prevention, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
- Issue published online: 2 DEC 2011
- Article first published online: 20 JUN 2011
- Manuscript Accepted: 25 APR 2011
- Manuscript Revised: 1 APR 2011
- Manuscript Received: 24 JAN 2011
- HPV vaccine;
- vaccine coverage
Since 2006, the human papillomavirus (HPV) vaccine has been routinely recommended for preadolescent and adolescent girls in the United States. Depending on uptake patterns, HPV vaccine could reduce existing disparities in cervical cancer.
HPV vaccination status and reasons for not vaccinating were assessed using data from the 2008 National Health Interview Survey. Households with a girl aged 9-17 years were included (N = 2205). Sociodemographic factors and health behaviors associated with vaccine uptake were assessed using multivariate logistic regression.
Overall, 2.8% of 9- to 10-year-olds, 14.7% of 11- to 12-year-olds, and 25.4% of 13- to 17-year-olds received at least 1 dose of HPV vaccine; 5.5% of 11- to 12-year-olds and 10.7% of 13- to 17-year-olds received all 3 doses. Factors associated with higher uptake in multivariate analysis included less than high school parental education, well-child check and influenza shot in the past year, and parental familiarity with HPV vaccine. Parents' primary reasons for not vaccinating were beliefs that their daughters did not need vaccination, that their daughters were not sexually active, or had insufficient vaccine knowledge. More parents with private insurance (58.0%) than public (39.8%) or no insurance (39.5%) would pay $360-$500 to vaccinate their daughters.
Less than one quarter of girls aged 9-17 years had initiated HPV vaccination by the end of 2008. Efforts to increase HPV uptake should focus on girls in the target age group, encourage providers to educate parents, and promote access to reduced-cost vaccines. Cancer 2011;. © 2011 American Cancer Society.